The use of an arylidene 2-indolinone derivative for treating tumors involving Met, PDGF-R, FGF-RI, FGF-R3 or Kit tyrosine kinases, or a Ret oncoprotein which includes a MEN2-associated mutation is disclosed.

 
Web www.patentalert.com

< Formulation for treating obesity and associated metabolic syndrome

> Stabilized Plant Extract and Its Therapeutic Use

> SILICATE CONTAINING COMPOSITIONS AND METHODS OF TREATMENT
~ 00519